Retrospective Cohort Study
Copyright ©The Author(s) 2023.
World J Clin Cases. Aug 16, 2023; 11(23): 5430-5439
Published online Aug 16, 2023. doi: 10.12998/wjcc.v11.i23.5430
Table 3 Analysis of laboratory examinations in the two groups, n (%)

Hemorrhage group, n = 6
Control group, n = 30
P value
WBC (109/L)6.05 ± 1.186.43 ± 1.600.584
RBC (1012/L)4.72 ± 0.434.75 ± 0.390.852
HBG (g/L)144.33 ± 10.73146.23 ± 11.900.720
PLT (109/L)189.83 ± 70.59227.70 ± 48.170.113
HCT (%)42.22 ± 3.6044.24 ± 8.290.565
ALT (IU/L)19.67 ± 9.7321.20 ± 11.780.767
AST (IU/L)19.33 ± 4.7221.67 ± 6.400.404
ALP (IU/L)69.83 ± 14.9361.63 ± 15.880.252
GLU (mmol/L)5.10 ± 0.495.69 ± 1.180.059
UREA (mmol/L)5.45 ± 1.675.29 ± 1.290.798
CREA (umol/L)67.00 ± 17.7562.23 ± 15.000.495
CHOL (mmol/L)4.61 ± 0.755.00 ± 1.010.375
ESR (mm)9.67 ± 7.428.97 ± 8.220.848
CRP (mg/dL)4.62 ± 5.362.58 ± 1.310.396
PT (s)11.70 ± 0.4211.35 ± 0.640.204
PA (%)102.98 ± 7.89109.86 ± 11.550.175
INR 0.98 ± 0.430.94 ± 0.500.092
APTT (s)26.67 ± 3.1225.17 ± 2.510.209
FIB (mg/dL)306.95 ± 67.93257.31 ± 68.430.114
D-dimer0.36 ± 0.170.42 ± 0.510.786